Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML). [electronic resource]
Producer: 20120917Description: 1327-8 p. digitalISSN:- 1432-0584
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Humans
- Induction Chemotherapy -- adverse effects
- Leukemia, Myeloid, Acute -- drug therapy
- Middle Aged
- Posterior Leukoencephalopathy Syndrome -- chemically induced
- Young Adult
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.